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Abstract
Serum response factor (SRF) acts as a multifunctional transcription factor regulated by mutually exclusive
interactions with ternary complex factors (TCFs) or myocardin-related transcription factors (MRTFs). Binding of Rho-
and actin-regulated MRTF:SRF complexes to target gene promoters requires an SRF-binding site only, whereas
MAPK-regulated TCF:SRF complexes in addition rely on flanking sequences present in the serum response element
(SRE). Here, we report on the activation of an SRE luciferase reporter by Tip, the viral oncoprotein essentially
contributing to human T-cell transformation by Herpesvirus saimiri. SRE activation in Tip-expressing Jurkat T cells
could not be attributed to triggering of the MAPK pathway. Therefore, we further analyzed the contribution of
MRTF complexes. Indeed, Tip also activated a reporter construct responsive to MRTF:SRF. Activation of this reporter
was abrogated by overexpression of a dominant negative mutant of the MRTF-family member MAL. Moreover,
enrichment of monomeric actin suppressed the Tip-induced reporter activity. Further upstream, the Rho-family
GTPase Rac, was found to be required for MRTF:SRF reporter activation by Tip. Initiation of this pathway was strictly
dependent on Tip’s ability to interact with Lck and on the activity of this Src-family kinase. Independent of Tip, T-
cell stimulation orchestrates Src-family kinase, MAPK and actin pathways to induce SRF. These findings establish
actin-regulated transcription in human T cells and suggest its role in viral oncogenesis.
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Background
Serum response factor (SRF) is widely expressed in both
invertebrates and vertebrates. SRF plays an essential role
in embryogenesis, but is also involved in multiple pro-
cesses in developed organisms including neuronal and
muscle cell function.
SRF binds as a dimer to a specific DNA sequence
known as the CArG box in the promoter of hundreds of
target genes. Selective binding is determined by interac-
tions with more than 60 different cofactors, which turn
SRF into a versatile transcription factor translating cell-
and stimulus-specific signaling into selective target gene
expression [1,2].
Well-known SRF cofactors are members of the ternary
complex factor (TCF) family of Ets domain proteins,
like Elk-1, SAP-1 and Net. They are regulated by
phosphorylation via the classical mitogen-activated pro-
tein kinase (MAPK) pathway involving the GTPase Ras,
which activates the serine-threonine kinases Raf, MEK
and ERK. Their recruitment to DNA depends on a
defined DNA sequence, called Ets motif (C/A)(C/A)
GGA(A/T), next to the SRF-binding CArG box [3,4]. A
serum response element (SRE), first described in the
c-fos promoter, contains an Ets motif adjacent to the
CArG box [5].
Another group of SRF cofactors are the myocardin-
related transcription factors (MRTFs). Myocardin, the
founding member of this family, is selectively expressed
in cardiac and smooth muscle cells and constitutively
binds SRF. In contrast, MRTF-A (MAL, MKL1, BSAC)
and MRTF-B (MAL16, MKL2) are widely expressed in
many cell types [6]. Their cofactor function is controlled
by GTPases of the Rho family (RhoGTPases), which are
considered as important regulators of the actin cytoske-
leton. Activation of the RhoGTPases RhoA, Rac1 and
Cdc42 results in the formation of focal adhesion
* Correspondence: Brigitte.Biesinger@viro.med.uni-erlangen.de
1Institut für Klinische und Molekulare Virologie, Friedrich-Alexander-
Universität Erlangen-Nürnberg, Erlangen, Germany
Full list of author information is available at the end of the article
Katsch et al. Cell Communication and Signaling 2012, 10:5
http://www.biosignaling.com/content/10/1/5
© 2012 Katsch et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.complexes, lamellipodia and filopodia, respectively [7].
These processes involve actin polymerization and
thereby reduce the levels of monomeric, globular actin
(G-actin). G-actin binds to N-terminal RPEL motifs of
MRTF and thereby sequesters and negatively regulates
MRTF. RhoGTPase-mediated reduction of G-actin liber-
ates MRTF, resulting in its nuclear accumulation and
SRF cofactor function. SRF-bound MRTF dimers
directly contact DNA near the SRF binding sequence.
However, a specific MRTF binding sequence, similar to
the Ets motif, has not yet been found [1,6].
Differential regulation of SRF target genes is based on
gene-specific cofactor preferences and cofactor competi-
tion for a common binding site on SRF [8-11]. In this
context, specific SRF functions are defined only for a
limited set of cell types and assignment of cofactors is
lagging. Conditional knock-out approaches were recently
used to elucidate the function of SRF and the role of
TCFs and MRTFs in mouse T cells. Elimination of SRF
b yaC D 4 - C r et r a n s g e n ea tt h eC D 4
+CD8
+ double posi-
tive stage impairs T-cell development and results in the
absence of peripheral T cells [12]. An earlier elimination
of SRF by a hCD2-Cre transgene at the CD4
-CD8
- dou-
ble negative stage severely reduces the numbers of single
positive thymocytes, thymic Treg a n dN KTc e l l s .I n t r o -
duction of recombinant SRF lacking the ability to bind
TCFs or MRTFs fails to restore thymocyte maturation.
In contrast, reconstitution was successful upon intro-
duction of wild-type SRF or a fusion of the recombinant
SRF with Elk [13]. While this study documents an
essential role of TCF:SRF complexes in T-cell develop-
ment, activation and function of MRTF:SRF complexes
in T cells remain to be established.
Herpesvirus saimiri (HVS) is the T-lymphotropic pro-
totype of g2-herpesviruses. In contrast to the apathogenic
appearance in its natural host, the squirrel monkey (Sai-
miri sciureus), HVS causes severe T-cell lymphoma in
experimentally infected non-natural primate hosts [14].
Most notably, in vitro infection of human peripheral
blood mononuclear cells with HVS strain C488 gives rise
to continuously proliferating T-cell lines [15]. Deletions
of viral genomic sequences coding for the oncoproteins
StpC (Saimiri transformation-associated protein of sub-
g r o u pC )a n dT i p( T y r o s i n ek i n a s ei n t e r a c t i n gp r o t e i n )
obviate human T-cell transformation as well as patho-
genicity in non-human primates [16]. Conditional
expression of Tip alone in transgenic mice leads to T-cell
lymphoma [17]. Tip engages the Src-family kinase (SFK)
Lck, a central mediator of proliferation in response to T-
cell receptor stimulation [18,19]. Lck interaction and
activation relies on two motifs in Tip, a sequence homo-
logous to the C-terminus of Src-family kinase domains
(CSKH) and a proline-rich Src homology domain 3 bind-
ing sequence (SH3B) [18,20,21]. The integrity of both
m o t i f s ,C S K Ha n dS H 3 B ,i sr e q u i r e df o rT i pt os u p p o r t
human T-cell transformation [22]. However, pro-prolif-
erative downstream effectors of Tip:Lck interaction are
not defined yet. Pro-oncogenic functions are character-
ized for signal transducer and activator of transcription 3
(STAT3) [23]. Indeed, STAT3 is activated by Lck in the
presence of Tip and is constitutively phosphorylated in
HVS-C488 transformed lymphocytes [21,24-26]. How-
ever, mutation of tyrosine residue 114 (Y114) in Tip
abrogates constitutive STAT3 phosphorylation, but not
viral transformation of human T cells [27,28]. Thus,
alternative Tip:Lck effectors must be involved to trigger
T-cell proliferation. Given the central role of mitogen-
activated protein kinases (MAPK) for growth regulation
in general, we previously analyzed MAPK phosphoryla-
tion and activation of MAPK-regulated transcription in
the presence of the HVS-C488 oncoproteins, StpC and
Tip [29]. In Jurkat T cells, neither StpC nor Tip induce
the phosphorylation of MEK1/2 and ERK1/2 or the activ-
ity of the MAPK-regulated transcription factor AP-1.
Nevertheless, Tip specifically triggers SRF activity in this
test system [29].
In this work, we now address the mechanism of SRF
activation by the viral oncoprotein Tip. We demonstrate
an SRF activation in T cells that depends on actin poly-
merization and on the cofactor MAL and is abrogated
by dominant-negative Rac1. Tip requires Lck interaction
and Src kinase activity to induce this pathway, which
may also be a target of T-cell receptor stimulation.
Results
Tip induces SRF-regulated transcription independent of
MAPK activity
We previously reported activation of a serum response ele-
ment (SRE) luciferase reporter by the viral oncoprotein
Tip in Jurkat T cells. This activation was not accompanied
by enhanced ERK1/2 or MEK1/2 phosphorylation [29]. To
further test for the impact of MAPK activity on Tip-
mediated SRE-reporter induction, transfected Jurkat T
cells were treated with the MEK inhibitors U0126 and
PD0325901. PMA, a chemical diacylglycerol analog known
to activate MAPK, was included as a positive control for
the inhibitory activity of these reagents (Figure 1). Activa-
tion of the SRE reporter by Tip was confirmed, but only
partially or non-significantly reduced by U0126 or
PD0325901 treatment. In contrast, PMA-induced reporter
activity, which was 2.8-fold higher compared to Tip-
expressing cells, was highly sensitive to MEK inhibition
(Figure 1A). These data were concordant with ERK1/2
phosphorylation detected by immunoblot analysis. Basal
phosphorylation was rather reduced by Tip, enhanced by
PMA and suppressed by the inhibitors (Figure 1C). As
Tip-induced SRE activity was not accompanied by MAPK
activity, we tested an alternative reporter (Figure 1B). The
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Ets motif within its SRE and is therefore more sensitive to
activation by MRTF:SRF complexes. Relative to the SRE
reporter, the p3D.A construct displayed a high basal activ-
ity in vector-transfected cells. An enhanced activity of this
reporter was observed for the MEK inhibitor U0126, but
not for PD0325901, indicating off-target functions and
restricting the validity of U0126 data. Tip induced a 3-fold
increase of the basal activity, and this enhancement was
not significantly affected by the MEK inhibitor
PD0325901. In contrast, PMA stimulation of vector-trans-
fected cells enhanced the activity about 7-fold, and this
effect was completely abrogated by U0126 and
PD0325901. Taken together, the viral oncoprotein Tip
induced SRF-responsive luciferase reporters independent
of MAPK activity and ERK phosphorylation. Activation of
the p3D.A luciferase reporter further points at SRF activa-
tion by Tip independent of the MAPK-TCF pathway.
SRF activation involves actin dynamics and the cofactor MAL
To corroborate MAPK and, thus, TCF independence of
Tip-mediated SRF activation, we next addressed the actin-
MRTF pathway. To this end, we transfected Jurkat T cells
with expression plasmids for wild-type actin (actin wt), an
actin polymerization mutant (actinR62D), wild-type full-
length MAL (MAL) and a MAL deletion mutant unable to
bind actin and SRF (MALΔNΔB1) alone or in combina-
tion with Tip (Figure 2A). Expression of the transfected
constructs was controlled by immunoblot analysis (Figure
2B). Overexpression of actin,p r e s u m a b l yr e s u l t i n gi n
excess globular actin, diminished the basal and Tip-
induced reporter activity by 3.5- and 2.2-fold, respectively.
This effect became more evident when globular actin was
enriched by overexpression of actinR62D, which reduced
the Tip-induced signal below basal levels. Upon overex-
pression of MAL, the basal reporter activity was 3.7-fold
higher compared to vector alone, and this was further
enhanced about 2.5-fold by coexpression of Tip. In con-
trast, the MAL deletion mutant completely abrogated the
signal. To strengthen these observations, we treated trans-
fected cells with Latrunculin B, an inhibitor of actin poly-
merization and promoter of filamentous actin disassembly.
As a positive control we used Cytochalasin D, which binds
G-actin irreversibly (Figure 2C). While enrichment of
monomeric actin by Latrunculin B inhibited both basal
and Tip-induced reporter activity, Cytochalasin D
increased the basal activity about 4-fold, but did not
further enhance the Tip effect. Thus, actin polymerization
and the cofactor MAL indeed play an important role in
SRF activation by Tip.
Figure 1 Tip activates SRF independent of MAPK. Jurkat T cells were transiently transfected with expression plasmids coding for the viral
oncoprotein Tip of HVS-C488. Empty vector served as a negative control. For inhibition of MAPK signaling, cells were left untreated or treated
with U0126 (25 μM), PD0325901 (1 μM) or solvent (DMSO) for 40 h. As positive controls, vector-transfected cell were stimulated with PMA (20
ng/ml) in the absence or presence of the MEK inhibitors for 15 h. (A) Activity of cotransfected pSRE-Luc displayed as mean values and standard
deviations of an assay performed in triplicates, which is representative for three independent experiments. Statistical significance for correlated
samples, p < 0.05 (*); p > 0.05 (ns). (B) Activity of cotransfected p3D.A-Luc summarized from six independent experiments. Statistical significance
for independent samples, p < 0.001 (***); p > 0.05 (ns). (C) Verification of MEK inhibition by detection of ERK1/2 phosphorylation and expression
as well as control of Tip expression by immunoblot analyses with whole cell lysates obtained 48 h post transfection
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activation
The importance of actin dynamics for Tip-induced SRF
activation raised the question whether the small
GTPases RhoA, Rac1, Cdc42, inducers of actin polymer-
ization and actin filament stabilization, play a role in
this process. Therefore, we used dominant-negative
expression constructs for Rac1 (Rac1-T17N) and RhoA
(RhoA-T19N) to further elucidate their role in p3D.A
reporter induction. Dominant-negative H-Ras (H-Ras-
S17N), a regulator of MAPK and TCFs, was used as a
control for interference between the small G proteins
(Figure 3A). Expression of the transfected constructs
was controlled by immunoblot analysis (Figure 3B).
Coexpression of RhoA-T19N and H-Ras-S17N did not
significantly reduce Tip-mediated reporter activity.
However, overexpression of Rac1-T17N impaired both
Tip’s effect on the reporter and background activity in
vector-transfected cells. Effector pull-down assays to
detect GTP-loaded Rac1/2/3 and Cdc42 (GST-PAK-
CRIB), RhoA (GST-Rhotekin) and H-Ras (GST-Raf-
RBD) suggested an activation of Rac and Cdc42, but not
RhoA and H-Ras by Tip (data not shown). However,
these findings were not constantly reproducible due to
high basal levels of activated Rac1/2/3 and Cdc42 in
vector-transfected cells. Nevertheless, the luciferase
reporter assays demonstrate a major role of the GTPase
Rac1, but not of RhoA and H-Ras, in the actin polymer-
ization- and MAL-dependent SRF activation by Tip.
p3D.A reporter activation by Tip depends on Src-family
kinase interaction and activity
To test for the properties of Tip required to induce SRF
activity, we used mutants of Tip defective in its major
effector function, the recruitment and activation of the
Src-family kinase (SFK) Lck, or carrying substitutions of
Figure 2 Effects of actin dynamics and the cofactor MAL on SRF activity. (A) p3D.A-Luc activity of Jurkat T cells transiently transfected with
expression plasmids coding for actin wt, actinR62D, MAL and MALΔNΔB1 alone or in combination with a Tip expression construct. (B)
Representative expression controls carried out by immunoblot analysis with whole cell lysates 48 h post transfection. Detection of Hsp90a/b
served as a loading control. (C) p3D.A-Luc activity of vector- and Tip-transfected cells treated with Latrunculin B (1 μM) and Cytochalasin D (1
μM) for 24 h. The graphs in (A) and (C) display the mean values and standard deviation of three independent experiments. Statistical
significance, p > 0.05 (ns); p < 0.05 (*); p < 0.01 (**)
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which may be targets of Lck [22,27,30] (Figure 4A).
Expression of the transfected constructs was controlled
by immunoblot analysis (Figure 4B). Deletion of the
CSKH motif (TipΔCSKH and TipΔCSKHmSH3B) or
individual point mutations of tyrosine residues 114
(TipY114F) and 127 (TipY127F) significantly reduced
SRF reporter activity to vector levels. The repression
observed upon mutation of the SH3 binding motif
(TipmSH3B) or tyrosine residue 155 (TipY155F) was
not significant. Furthermore, interpretation of the data
for TipY127F and TipY155F is restricted by their
expression levels, which were reproducibly reduced rela-
tive to the wild-type protein. The abolishment of Tip-
mediated reporter activatio nb yt h eh i g h l ys p e c i f i cS F K
inhibitor PP2 verified the requirement of Src-kinase
activity (Figure 4C). Immunoblot analysis of protein tyr-
osine phosphorylation monitored a modulating function
of Tip and the inhibitory efficacy of PP2 (Figure 4D).
Hence, Tip relies on both, Lck interaction and SFK
activity, to trigger MAL:SRF reporter activity. Further-
more, tyrosine residues Y114 and Y127, known to be
critical for STAT3 activation [28] and IL-2-independent
T-cell transformation [22], respectively, likely contribute
to Tip-induced SRF activity.
TCR stimulation induces p3D.A reporter activity
The viral oncoprotein Tip activated SRF in T cells via the
actin-regulated cofactor MAL (Figure 2), while previous
reports demonstrated SRF activation via the MEK-ERK
pathway in response to TCR stimulation of Jurkat T cells
and in mouse T-cell development [13,31]. This discrepancy
prompted us to assess whether TCR stimulation alone can
trigger the p3D.A luciferase reporter or further enhance
the Tip effect (Figure 5A). TCR and coreceptor engage-
ment via CD3/CD28 antibodies resulted in a 10-fold
enhanced reporter activity in vector-transfected Jurkat T
cells relative to unstimulated cells. In contrast, CD3/CD28
antibody treatment did not significantly augment the Tip-
triggered signal. As ERK phosphorylation was absent in
Tip-transfected cells (Figure 5B), this lack of cooperation
correlated with an impaired CD3/CD28-induced signaling,
which is in accordance with suppression of TCR signaling
by Tip [32]. In order to specify the TCR-triggered pathway
involved, CD3/CD28-stimulated and unstimulated vector-
transfected cells were treated with inhibitors of SFK (PP2),
MEK (PD0325901), and actin polymerization (Latrunculin
B) (Figure 5C). TCR-induced reporter activity was signifi-
cantly reduced in all treated samples. All three inhibitors
were similarly effective, with low but significant residual
activities relative to unstimulated cells. Unexpectedly, the
residual activities in PD0325901- and Latrunculin B-treated
cells did not add up to the activity of solvent-treated cells
(DMSO). This finding may be related to the partial reduc-
tion of ERK phosphorylation by Latrunculin B (Figure 5D).
The impact of actin polymerization on SRF activation in T
cells was further addressed by the expression of constitu-
tively active Rac1 (Rac1-G12V) and RhoA (RhoA-Q63L) in
the Jurkat system (Figure 5E). Rac1-G12V and RhoA-Q63L
(Figure 5E) were equally effective and even more potent
than CD3/CD28 stimulation (Figure 5A, C) in inducing
3D.A reporter activity. In conclusion, TCR stimulation
relied on both, MAPK signaling and actin polymerization,
to activate SRF.
Discussion
Our study revealed that the oncoprotein Tip of Herpes-
virus saimiri (HVS) activates the serum response factor
Figure 3 Influence of dominant-negative GTPases on SRF activation. Jurkat T cells were transiently transfected with expression plasmids
coding for myc-Rac1-T17N (RacT17N), RhoA-T19N (RhoT19N) and H-Ras-S17N (RasS17N) alone or in combination with a Tip expression construct.
(A) Activity of cotransfected p3D.A-Luc displayed as mean values and standard deviation of three independent experiments. Statistical
significance, p > 0.05 (ns); p < 0.01 (**). (B) Representative expression control carried out by immunoblot analysis. Detection of b-tubulin served
as a loading control
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actin-mediated MRTF coactivation, with minor contri-
butions of MEK-mediated TCF coactivation. Discrimina-
tion of coactivator involvement was assessed using two
SRF-dependent luciferase reporter constructs, based on
the c-fos SRE, considered to be specific for TCF coacti-
vation, and on a mutated SRE (3D.A), considered to
respond preferentially to MRTF coactivation. However,
largely MEK-independent SRE activation by Tip and
MEK-sensitive 3D.A activation by PMA revealed a
restricted specificity of the reporters in the Jurkat T
cells used throughout this study. Hence, we included
chemical inhibitors and overexpression of mutant
signaling intermediates to assign Tip-induced SRF acti-
vation to the actin-dependent MRTF coactivation path-
way. Targeting of this pathway by a viral T-cell
oncoprotein was unexpected, as SRF function in T cells
had previously been linked mainly to the TCF pathway
[13].
SRF activation in our system strictly relied on the abil-
ity of Tip to engage Lck. This interaction is reported to
result in kinase activation [25,33-35], which is also well-
known as an initial step in T-cell activation. Indeed, inde-
pendent of Tip, CD3/CD28 stimulation triggered the 3D.
A reporter through Src-family kinase (SFK) activity and
b o t h ,T C Fa n dM R T Fp a t h w a y s .T h e s ef i n d i n g sa r ei n
Figure 4 The role of Src-kinase interactions of Tip for SRF activation. (A) Jurkat T cells were transiently transfected with expression plasmids
coding for wild-type Tip or its mutants TipΔCSKH, TipmSH3B, TipΔCSKHmSH3, TipY114F, TipY127F and TipY155F. Empty vector (pEF1) served as
negative control. Activation of cotransfected p3D.A-Luc displayed as mean values and standard deviation of three independent experiments.
Statistical significance, p > 0.05 (ns); p < 0.05 (*). (B) Expression control for Tip and its mutants in total lysates obtained from the cells described
in (A). (C) Vector and Tip constructs were cotransfected with p3D.A-Luc into Jurkat T cells, and SFK activity was blocked by PP2 treatment (10
μM) for 40 h. The graph summarizes the reporter activities of six independent experiments. Statistical significance, p > 0.05 (ns); p < 0.001 (***).
(D) Total cellular protein tyrosine phosphorylation (pY) and Tip expression in the cells described in (C). Detection of Hsp90a/b served as a
loading control
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scription in Jurkat T cells [31]. Thus, Lck-dependent
MRTF coactivation, which we suggest for Tip, may as
well apply to T-cell stimulation. However, while Tip trig-
gers SRF largely independent of MAPK activity, stimula-
tion-induced SRF activation substantially involves MAPK
signaling and likely integrates different intracellular sig-
naling routes. The interference of Tip with receptor-
mediated SRF activation most likey occurs further
upstream. Dependent on its localization in lipid rafts, Tip
induces the internalization of TCR complexes [36-38].
Independent of its lipid raft association, Tip blocks TCR-
mediated intracellular signaling most likely through
sequestration of Lck [32,38]. Consequently, Tip-expres-
sing cells are refractory to receptor ligation by stimulat-
ing antibodies.
Figure 5 SRF activation by TCR engagement and by constitutively active Rac1 or RhoA. (A) Jurkat T cells were transiently transfected with
p3D.A-Luc and vector or expression plasmids coding for Tip and stimulated for 14 h in 6-well plates coated with antibodies directed against
CD3 and CD28 (aCD3/CD28). Reporter activation is summarized as mean values and standard error of five independent experiments. Statistical
significance, p > 0.05 (ns); p < 0.01 (**). (B) Representative immunoblots for the cells used in (A) displaying ERK1/2 phosphorylation and
expression as well as Tip expression. (C) Jurkat T cells were transiently transfected with p3D.A-Luc and vector. Cells were treated with PP2 (10
μM, 40 h), PD0325901 (1 μM, 40 h) or Latrunculin B (1 μM, 24 h) and stimulated for 14 h in 6-well plates coated with antibodies directed against
CD3 and CD28 (aCD3/CD28). Reporter activation is summarized as mean values and standard deviation of three independent experiments.
Statistical significance, p < 0.05 (*); p < 0.01 (**); p < 0.001 (***). (D) Representative immunoblots for the cells described in (C) displaying ERK1/2
phosphorylation and expression. (E) Vector and expression plasmids coding for Tip, myc-Rac1-G12V (RacG12V) or myc-RhoA-Q63L (RhoQ63L)
were cotransfected with p3D.A-Luc. The graph summarizes data of five independent experiments. Statistical significance, p < 0.001 (***). (F)
Representative immunoblots displaying myc-Rac1-G12V, myc-RhoA-Q63L and Tip expression. Detection of b-tubulin served as a loading control
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interaction, Src-family kinase (SFK) activity and the
potential Lck phosphorylation sites in Tip, Y114 and
Y127, draws the attention to the Tip:Lck effectors
involved in this pathway. So far, only STATs, especially
STAT3, are described as direct targets of Tip-activated
Lck [21,24-27]. Tip-induced STAT3 activation depends
on residue Y114, which is not required for human T-
cell transformation in vitro [28]. However, the potential
of STAT3 to promote invasion in various cancers [23]
may well relate to the massive tissue invasion by HVS-
lymphoma cells [26,39], which is not reflected in the cell
culture system. Therefore, while effectorso fT i pe s s e n -
tial for viral T-cell transformation are still not identified,
w es u g g e s tt h a tT i pY 1 1 4c o n t r i b u t e st ov i r a lo n c o g e n -
esis through STAT3-regulated lymphocyte invasion. In
this context, STAT3 would be expected as an upstream
regulator of RhoGTPases. However, an emerging model
positions STAT3 downstream of Rac1 and Cdc42 in the
regulation of cell proliferation and migration [40]. Alter-
natively, transcriptional regulation of genes involved in
MRTF:SRF activation by Tip-induced STAT3 appears
conceivable. Such an indirect mechanism might also be
elicited by STAT5, a recently identified target of Tip
[41] likely related to the strict IL-2 dependence of viral
transformation in the presence of TipY127F [22]. In any
case, a functional link between STAT3 or STAT5 and
MRTF:SRF, to the best of our knowledge, has not been
reported. Hence, Tip-activated Lck may trigger SRF acti-
vation through alternative, yet unknown effectors like
the various RhoGTPase guanine nucleotide exchange
factors (GEFs) expressed in T cells [42]. Altogether,
mechanisms of MRTF:SRF activation proximal to the
Tip:Lck complex remain to be established.
The RhoGTPases RhoA, Rac1 and Cdc42 directly reg-
ulate actin cytoskeleton organization [7] and therefore
share the potential to modulate cellular G-actin pools,
which in turn determine MRTF coactivator availability
[1]. We expressed constitutively active Rac1 and RhoA
and thereby proved the inducibility of MRTF:SRF by
both GTPases in T cells independent of Tip. Dominant-
negative versions of Rac1, RhoA and Ras were used to
test for the involvement of these GTPases in Tip-
mediated SRF activation. The missing influence of domi-
nant-negative Ras corroborated the TCF independence
of Tip-induced SRF activation. Suppression of the Tip
effect by inhibitory Rac1 and not RhoA is in contrast to
the initial report on SRF activation by MAL in NIH3T3
fibroblasts [8], but in accordance with MAL signaling in
epithelial cells [43]. We assumed that Tip induces SRF
via Rac1, but not RhoA. Accordingly, active (GTP-
bound) RhoA and H-Ras were not detected in Tip-
expressing cells, whereas cellular levels of basally active
Rac1 and Cdc42 were enhanced by Tip in some, but not
all effector pull-down assays performed. We further
used the Rac1/Cdc42-glucosylating C. difficile toxins
that have been shown to inhibit SRF activation induced
by Ca
2+-dependent dissociation of epithelial integrity
[43]. Unexpectedly, the C. difficile toxins failed to sup-
press Tip-induced reporter activity in our Jurkat system
(data not shown). This observation is apparently incon-
sistant with our observation that Rac1-T17N strongly
reduces Tip-induced SRF activation. In general, either
pronounced Rac1/Cdc42 activation or pronounced
Rac1/Cdc42 phosphorylation by Akt1 protects Rac1/
Cdc42 from toxin-catalyzed glucosylation and inactiva-
tion [44,45]. In particular, protective phosphorylation of
Rac1/Cdc42 has to be taken into account, as Jurkat T
cells are deficient in expression of PTEN, a major nega-
tive regulator of PI3K/Akt signaling [46]. Based on the
data available, we would exclude RhoA and Ras and
suggest Rac1 and Cdc42 activation in response to Tip
expression as the crucial step in SRF induction. The
mechanism of the Tip-mediated activation of Rac1/
Cdc42, however, remains to be clarified.
Besides the critical role of Rac1 in Tip-induced SRF
activation, our results substantiate an essential role of
actin and actin-regulated MRTF in SRF activation by
Tip in T cells. The syngergism between ectopic MAL
and the viral oncoprotein, which is in contrast to the
effects obtained with the cellular oncoprotein OTT-
MAL [47], points at limiting MAL expression levels and
clearly positions Tip upstream in the activation cascade.
However, although we used wild-type and mutant MAL
expression constructs, our assays are not suited to dis-
criminate the contribution of the individual MRTF-
family proteins, MAL/MRTF-A and MRTF-B, which
may add another layer of complexity to SRF regulation.
MRTF:SRF functions in T cells are not characterized
yet, and T cell-specific target genes of this transcription
factor complex are not known. However, transcription
of cytoskeletal regulators like MYH9 and MYL9 is ele-
vated in different non-lymphoid cancer cell lines, which
depend on MRTFs and SRF for cell spreading, adhesion,
and motility [48]. Thus, MRTF:SRF activation by Tip, a
viral oncoprotein essential for the development of fulmi-
nant T-cell lymphoma characterized by infiltration of
multiple organs [16,26], may well contribute to viral
oncogenesis and tissue invasion of tumor cells.
Conclusion
Our study on cellular signaling by the viral oncoprotein
Tip demonstrates SRF coactivation by MRTFs and not
TCFs in T cells. MRTF:SRF induction depended on
actin polymerization and RhoGTPase activity as well as
Tip:Lck interaction and SFK activity (Figure 6). Further-
more, our data hint at MRTF:SRF activation by TCR sti-
mulation independent of Tip. Future studies will have to
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pathway triggered by Tip as well as its applicability to T
cells in general. This approach is anticipated to resolve
the functional relevance of MRTF:SRF activity in T-cell
regulation and in viral oncogenesis.
Methods
Cell culture
Jurkat T cells (E6.1, ATCC TIB-152) were cultured in
RPMI 1640 medium supplemented with 10% fetal calf
serum (FCS), glutamine (350 μg/ml) and gentamicin
(100 μg/ml) at a maximum concentration of 0.5-1 ×10
6
cells/ml.
Transient transfection of Jurkat T cells
Transfection of 5-10 ×10
6 cells/ml Jurkat T cells was
carried out by electroporation in medium without anti-
biotics at 250 V, 1,500 μFu s i n gaG e n ep u l s e r×c e l l ™
Electroporation System (Bio-Rad). For each sample, a
total of 50 μg plasmid DNA was used and appropriate
empty vector was included to equalize plasmid DNA
amounts. Transfected cells, cultured in complete med-
ium without antibiotics, were harvested after 48 h,
washed with phosphate-buffered saline (PBS) and pro-
cessed for luciferase reporter gene assays or immunoblot
analysis.
Expression plasmids
Jurkat T cells were transfected with 20 μgo fe x p r e s s i o n
constructs coding for wild type and mutants of the viral
oncoprotein Tip derived from HVS-C488: pEF1-Tip,
pEF1-TipΔCSKH, pEF1-TipmSH3B, pEF1-TipΔCSKHm
SH3B, pEF1-TipY114F, pEF1-TipY127F, pEF1-TipY155F
[49]. All Tip constructs are N-terminally myc-tagged. The
expression plasmids pEF-FLAG-actin wt; pEF-FLAG-
actinR62D, coding for a FLAG-tagged polymerization
TCF
MAL
Rac
MEK1/2
ERK1/2
Ras
cytoplasm
MAL
SRF
F-actin
G-actin
CArG
nucleus
SRF
CArG Ets motif
Tip
Lck
STAT3
MAL MAL
TCF
Figure 6 Model for Tip-induced SRF activation. The membrane-associated viral oncoprotein Tip engages and activates the Src-family kinase
Lck. This interaction is required for STAT3 phosphorylation and for MAL:SRF activation. Signaling flux from Tip:Lck to the RhoGTPases Rac
remains to be established (dashed line). Rac promotes a decrease in the G-actin/F-actin ratio and thereby enables nuclear translocation of MAL
and coactivation of SRF-dependent gene expression. Tip:Lck is not linked to Ras, MEK1/2, or ERK1/2 and subsequent TCF activation
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Page 9 of 12mutant of actin; pEF-MAL-HA (f.l.), encoding HA-tagged
full-length murine MAL; pEF-MALΔNΔB1-HA, coding
for a MAL deletion mutant unable to bind to actin and
SRF, were described previously [8,50]. Sequences coding
for dominant-negative Rac1 (RacT17N) and RhoA
(RhoT19N) and constitutively active Rac1 (RacG12V) and
RhoA (RhoQ63L) were amplified by PCR with oligonu-
cleotide primers introducing terminal BamHI and EcoRI
restriction sites and a N-terminal myc-tag (myc-RacT17N,
myc-RacG12V, myc-RhoQ63L) (primers available upon
request) were cloned into pEF1 to yield the expression
constructs pEF1-myc-RacT17N, pEF1-RhoT19N, pEF1-
myc-RacG12V and pEF1-myc-RhoQ63L. Dominant-nega-
tive Ras was expressed using the plasmid pcDNA3-
RasS17N (kindly provided by A. Wittinghofer, Dortmund,
Germany). Integrity of the coding sequences was con-
firmed by automated DNA sequencing (ABI 3130, Applied
Biosystems).
Immunoblot analysis
Jurkat T cells were lysed in RIPA buffer and processed
as previously described to generate whole cell lysates
[29]. Protein extracts of 0.5-1 ×10
6 Jurkat T cells were
loaded on SDS-polyacrylamide gels and transferred to
polyvinylidene difluoride membranes (GE Healthcare).
After blocking with 5% milk powder in 0.1% Tween20-
PBS or NET-gelatine (150 mM NaCl; 5 mM EDTA; 50
mM Tris-HCl pH7.5; 0.05% TritonX-100; 2.5 g/ml gela-
tine), the membranes were probed with antibodies direc-
ted against: phosphotyrosine (4 G10, Millipore), pERK1/
2 (pY204 in ERK1), Hsp90a/b (Santa Cruz), ERK1/2,
RhoA, Rac1/2/3 (Cell Signaling Technology), Pan-Ras
(Calbiochem), Tip [17], Myc-epitope (9E10; ATCC CRL-
1729), FLAG-epitope (M2, HRP-coupled; Sigma), HA-
epitope (Convance), b-tubulin (GE Healthcare). Binding
of primary antibodies was detected using horseradish
peroxidase-coupled secondary antibodies directed
against mouse or rabbit immunoglobulins (Dako). Pri-
mary and secondary antibodies were diluted in blocking
buffer. Immunodetection was performed by chemilumi-
nescence and documented with a Kodak Image Station
4000 MM PRO camera.
Luciferase reporter gene assay
Jurkat T cells were transfected with 20 μgo ft h ei n d i v i -
dual effector plasmids and 10 μg of the reporter plasmid
pSRE-luc containing five SRE of the c-fos promoter
(Stratagene) or p3D.A-Luc [51] comprising three SRE
with a mutated Ets motif. Cells were harvested 48 h
post transfection and divided equally for luciferase activ-
ity quantification and immunoblots. For luciferase
reporter gene assay, cells were lysed and luminescence
intensity was measured as described [52]. Raw data were
normalized to the protein content of each sample as
determined by a BCA assay (Uptima) and indicated as
relative light units (RLU). Data were statistically evalu-
ated with two-tailed t-tests for correlated (Figure 1A) or
independent (all other figures) samples using the online-
tools provided by the VassarStats Website for Statistical
Computation [http://faculty.vassar.edu/lowry/Vassar-
Stats.html]. Results were assigned to the categories p >
0.05 (ns, not significant), p < 0.05 (*), p < 0.01 (**), p <
0.001 (***).
Inhibitor treatment and CD3/CD28 ligation
For inhibitor treatment, transfected Jurkat T cells were
s e e d e di na1 2 - w e l lp l a t ea tad e n s i t yo fa p p r o x i m a t e l y
0.5 ×10
6 cells/ml. The SFK inhibitor PP2 (Sigma; 10
μM) and the MAPK inhibitors U0126 (Biomol Germany;
25 μM) and PD0325901 (1 μM) were added 8 h post
transfection and remained in the cultures until harvest-
ing of the cells. 12-O-tetradecanoylphorbol-13-acetate
(PMA; Sigma; 20 ng/ml), combined with MAPK inhibi-
tors if applicable, was added for 15 h. To modulate
actin polymerization, cells were treated with Latrunculin
B (Calbiochem; 1 μM), Cytochalasin D (Applichem; 1
μM) for 24 h. Under these conditions all inhibitors were
not toxic to Jurkat T cells as measured by propidiumio-
dide staining and flow cytometry. T cell-receptor stimu-
lation of transfected Jurkat T cells was carried out for
14 h in a 6-well plate at a density of approximately 1 ×
10
6 cells/ml previously coated with antibodies against
CD3 (OKT3; Janssen-Cilag; 10 μg/ml) and CD28 (a gift
from R. Kroczek, Robert Koch-Institut, Berlin; 5 μg/ml).
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